
Sign up to save your podcasts
Or
Guest: Mohamad Bydon, M.D.
Host: Jeffrey S. Brault, D.O. (@JeffBrault)
Dr. Mohamad Bydon discusses harnessing autologous, adipose-derived, mesenchymal stem cells to treat blunt traumatic spinal cord injuries. He details how the the ground-breaking clinical trial is setup, the safety and efficacy goals of the current study, and what they hope to do in phase two.
Connect with the Mayo Clinic’s PM&R Department on Twitter @MayoClinicPMR.
Deeper Dive:
5
1818 ratings
Guest: Mohamad Bydon, M.D.
Host: Jeffrey S. Brault, D.O. (@JeffBrault)
Dr. Mohamad Bydon discusses harnessing autologous, adipose-derived, mesenchymal stem cells to treat blunt traumatic spinal cord injuries. He details how the the ground-breaking clinical trial is setup, the safety and efficacy goals of the current study, and what they hope to do in phase two.
Connect with the Mayo Clinic’s PM&R Department on Twitter @MayoClinicPMR.
Deeper Dive:
281 Listeners
12 Listeners
248 Listeners
15 Listeners
9 Listeners
46 Listeners
16 Listeners